RhumbLine Advisers’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.47M Buy
100,614
+4,720
+5% +$112K ﹤0.01% 1748
2025
Q4
$2.38M Sell
95,894
-1,448
-1% -$38.5K ﹤0.01% 1772
2025
Q3
$2.76M Sell
97,342
-19,179
-16% -$520K ﹤0.01% 1731
2025
Q2
$2.9M Buy
116,521
+1,714
+1% +$48.3K ﹤0.01% 1678
2025
Q1
$3.56M Sell
114,807
-94
-0.1% -$3.13K ﹤0.01% 1526
2024
Q4
$3.62M Sell
114,901
-1,049
-0.9% -$49.8K ﹤0.01% 1583
2024
Q3
$6.72M Sell
115,950
-5,074
-4% -$249K 0.01% 1264
2024
Q2
$4.91M Buy
121,024
+49
+0% +$1.94K ﹤0.01% 1415
2024
Q1
$5.08M Buy
120,975
+1,007
+0.8% +$39.3K ﹤0.01% 1413
2023
Q4
$4.59M Sell
119,968
-8,663
-7% -$288K ﹤0.01% 1473
2023
Q3
$3.97M Buy
128,631
+3,565
+3% +$123K ﹤0.01% 1484
2023
Q2
$3.95M Buy
125,066
+5,289
+4% +$181K ﹤0.01% 1524
2023
Q1
$4.37M Buy
119,777
+5,421
+5% +$190K 0.01% 1407
2022
Q4
$3.38M Buy
114,356
+8,801
+8% +$283K ﹤0.01% 1517
2022
Q3
$4.12M Buy
105,555
+5,658
+6% +$259K 0.01% 1348
2022
Q2
$3.85M Buy
99,897
+7,091
+8% +$270K 0.01% 1395
2022
Q1
$4.5M Buy
92,806
+6,484
+8% +$334K 0.01% 1383
2021
Q4
$6.34M Sell
86,322
-1,685
-2% -$138K 0.01% 1232
2021
Q3
$8.01M Buy
88,007
+28,401
+48% +$2.42M 0.01% 1079
2021
Q2
$3.74M Buy
59,606
+39,075
+190% +$1.44M ﹤0.01% 1599
2021
Q1
$556K Sell
20,531
-1,345
-6% -$32.4K ﹤0.01% 2440
2020
Q4
$400K Buy
21,876
+2,668
+14% +$48K ﹤0.01% 2530
2020
Q3
$345K Buy
19,208
+1,254
+7% +$21.6K ﹤0.01% 2456
2020
Q2
$296K Buy
17,954
+2,235
+14% +$35.2K ﹤0.01% 2584
2020
Q1
$203K Sell
15,719
-301
-2% -$4.91K ﹤0.01% 2576
2019
Q4
$295K Sell
16,020
-13,805
-46% -$229K ﹤0.01% 2597
2019
Q3
$526K Buy
+29,825
New +$510K ﹤0.01% 2301
2018
Q3
Sell
-22,078
Closed -$571K 2938
2018
Q2
$571K Buy
+22,078
New +$378K ﹤0.01% 2244

Other funds holding ASTH